Trial Profile
A Pharmacokinetic study of Isavuconazole levels in patients with chronic pulmonary aspergillosis
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 May 2017
Price :
$35
*
At a glance
- Drugs Isavuconazole (Primary)
- Indications Aspergillosis
- Focus Pharmacokinetics
- 14 May 2017 New trial record
- 25 Apr 2017 Results presented at the 27th European Congress of Clinical Microbiology and Infectious Diseases